The Clorox Company (NYSE:CLX) Shares Purchased by Graypoint LLC

Graypoint LLC grew its holdings in shares of The Clorox Company (NYSE:CLXFree Report) by 28.0% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 3,899 shares of the company’s stock after purchasing an additional 854 shares during the quarter. Graypoint LLC’s holdings in Clorox were worth $635,000 at the end of the most recent quarter.

A number of other large investors have also modified their holdings of the business. Insight Folios Inc increased its holdings in shares of Clorox by 3.0% in the 3rd quarter. Insight Folios Inc now owns 2,195 shares of the company’s stock valued at $358,000 after acquiring an additional 63 shares during the last quarter. GHP Investment Advisors Inc. increased its stake in Clorox by 2.0% in the second quarter. GHP Investment Advisors Inc. now owns 3,634 shares of the company’s stock valued at $496,000 after purchasing an additional 72 shares during the last quarter. Fiduciary Group LLC raised its holdings in Clorox by 0.4% during the second quarter. Fiduciary Group LLC now owns 19,050 shares of the company’s stock worth $2,600,000 after purchasing an additional 72 shares in the last quarter. SPC Financial Inc. raised its holdings in Clorox by 2.2% during the second quarter. SPC Financial Inc. now owns 3,485 shares of the company’s stock worth $476,000 after purchasing an additional 75 shares in the last quarter. Finally, Massmutual Trust Co. FSB ADV lifted its position in shares of Clorox by 17.2% during the 3rd quarter. Massmutual Trust Co. FSB ADV now owns 510 shares of the company’s stock worth $83,000 after buying an additional 75 shares during the last quarter. Hedge funds and other institutional investors own 78.53% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts recently commented on the stock. Citigroup lifted their price target on shares of Clorox from $165.00 to $170.00 and gave the stock a “neutral” rating in a research note on Friday, September 6th. Deutsche Bank Aktiengesellschaft lifted their target price on shares of Clorox from $144.00 to $151.00 and gave the company a “hold” rating in a report on Friday, August 2nd. BNP Paribas upgraded shares of Clorox to a “strong sell” rating in a research note on Friday, September 6th. TD Cowen upgraded shares of Clorox from a “sell” rating to a “hold” rating and lifted their price objective for the company from $155.00 to $170.00 in a research note on Wednesday. Finally, DA Davidson increased their target price on shares of Clorox from $153.00 to $171.00 and gave the stock a “neutral” rating in a research note on Monday, November 4th. Five equities research analysts have rated the stock with a sell rating, ten have given a hold rating and one has assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Hold” and a consensus target price of $155.00.

Read Our Latest Stock Analysis on CLX

Clorox Stock Up 1.5 %

CLX opened at $165.20 on Friday. The company has a debt-to-equity ratio of 11.08, a current ratio of 1.00 and a quick ratio of 0.62. The Clorox Company has a 12 month low of $127.60 and a 12 month high of $169.09. The stock has a market capitalization of $20.45 billion, a P/E ratio of 57.56, a P/E/G ratio of 3.02 and a beta of 0.41. The business has a 50 day simple moving average of $162.14 and a 200-day simple moving average of $146.83.

Clorox (NYSE:CLXGet Free Report) last issued its earnings results on Wednesday, October 30th. The company reported $1.86 EPS for the quarter, topping the consensus estimate of $1.36 by $0.50. The company had revenue of $1.76 billion for the quarter, compared to analyst estimates of $1.64 billion. Clorox had a net margin of 4.78% and a return on equity of 316.08%. The business’s revenue was up 27.0% on a year-over-year basis. During the same period in the previous year, the firm earned $0.49 EPS. On average, equities analysts anticipate that The Clorox Company will post 6.81 earnings per share for the current fiscal year.

Clorox Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Thursday, November 7th. Stockholders of record on Wednesday, October 23rd were given a dividend of $1.22 per share. The ex-dividend date of this dividend was Wednesday, October 23rd. This represents a $4.88 dividend on an annualized basis and a dividend yield of 2.95%. Clorox’s payout ratio is 170.04%.

Insider Transactions at Clorox

In related news, EVP Angela C. Hilt sold 1,733 shares of Clorox stock in a transaction on Friday, September 6th. The stock was sold at an average price of $165.52, for a total transaction of $286,846.16. Following the completion of the transaction, the executive vice president now directly owns 13,471 shares of the company’s stock, valued at approximately $2,229,719.92. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Corporate insiders own 0.57% of the company’s stock.

Clorox Company Profile

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Featured Articles

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.